Very true TL.
Everything is trending beyond expectations.
Revenue numbers, rate of recruitment, lesser rate of drop out. Everything
Acadia can’t spell it out more. The majority of the remaining Rett market will only now begin to be targeted.
As each quarter rolls on, we get closer to adding ROW regions.
800 patients ~ US$70m for the quarter
This isn’t a forecast. It just happened
3200 patients ~ US$280m for a quarter
This is a forecast and a realistic medium term goal.
Not sure what else people need to see to make them aware of what’s going on here - irrespective of 2591 or fragile-x
Daybue Rollout, page-100
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $5.043M | 365.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $13.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |